Ingersoll Rand Inc. · NYSE:IR
Ingersoll Rand — Gardner Denver — Q1 2019 Earnings Presentation
15 slides from Ingersoll Rand's earnings presentation, Apr 30, 2019
Slide 1: Gardner Denver Q1 2019 Earnings Presentation
Gardner Denver Q1 2019 Earnings Presentation April 30, 2019
Slide 2: Replay Information
Replay Information ▪ Dial toll-free: +1.877.344.7529 ▪ International: +1.412.317.0088 ▪ Conference ID: #10130797 ▪ Log on to: http://investors.gardnerdenver.com 2
Slide 3: Disclaimer
Disclaimer Forward-Looking Statements During the course of this presentation, we may make “forward-looking statements” within the meaning of the US federal securities laws. In fact, all statements made during this presentation other than statements of historical fact are forward-looking statements.
Slide 4: Agenda
Agenda ▪ Company Highlights ▪ Segment Highlights ▪ Guidance ▪ Q&A 4
Slide 5: Q1 2019 Highlights
Q1 2019 Highlights1 Q1 performance consistent with expectations… reaffirming full year 2019 guidance Revenue of $620M, flat, and up 4% excluding FX Known pressure in upstream Energy mitigated by the rest of portfolio, including solid performance in mid/downstream Energy businesses GDP-exposed
Slide 6: Our Strategy
Our Strategy Deploy Talent Expand Margins Accelerate Growth Allocate Capital Effectively 6
Slide 7: Industrials Segment – Q1 Highlights
Industrials Segment – Q1 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $318.1 $316.9 0.4% 5.6% Adjusted EBITDA $71.0 $66.8 6.3% 12.0% Adjusted EBITDA Margin 22.3% 21.1% 120 bps Innovation in Action Highlights: Orders up 4% ex-FX Revenue up 6% ex-FX
Slide 8: Energy Segment – Q1 Highlights
Energy Segment – Q1 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $233.1 $242.2 (3.8)% (1.1)% Adjusted EBITDA $60.0 $68.0 (11.8)% (10.4)% Adjusted EBITDA Margin 25.7% 28.1% (240) bps Innovation in Action Highlights: Orders down 26% ex-FX Revenue down
Slide 9: Medical Segment – Q1 Highlights
Medical Segment – Q1 Highlights (Dollars in millions) As Prior YOY Ex-FX YOY Reported Year Change Change Revenue $69.1 $60.5 14.2% 19.1% Adjusted EBITDA $20.0 $15.9 25.8% 32.1% Adjusted EBITDA Margin 28.9% 26.3% 260 bps Innovation in Action Highlights: Orders down 1% ex-FX… on top of 11% growth in
Slide 10: Reaffirming 2019 Guidance
Reaffirming 2019 Guidance Revenue Adjusted Phasing Growth1 EBITDA Revenue Growth1 Excluding impact of FX: Industrials up MSD Medical up MSD Mid and Downstream Energy up MSD Upstream Energy down LDD to HSD Corporate -- Total Gardner Denver ~$710M - $740M H1: up LSD to MSD up LSD to MSD H2: up LSD to
Slide 11: Reaffirming 2019 Guidance (continued)
Reaffirming 2019 Guidance (continued) Capital Expenditures ~$50M - $60M Tax Rate 24% to 26% Year End Net Debt Leverage1 1.5x to 1.7x Average Shares Outstanding2 ~208M 1 Excluding the impact of any potential M&A activity or share repurchases 2 Represents the expectation of weighted average diluted sh
Slide 12: Appendix
Appendix
Slide 13: Reconciliation of Net Income and EPS to Adjusted Net Income and Adjusted EPS
Reconciliation of Net Income and Earnings per Share to Adjusted Net Income and Adjusted Earnings per Share 13
Slide 14: Reconciliation of Net Income to Adjusted EBITDA and CFOA to Free Cash Flow
Reconciliation of Net Income to Adjusted EBITDA and Adjusted Net Income and CFOA to Free Cash Flow 14
Slide 15: Reconciliation of Segment Adjusted EBITDA to Income/(Loss) Before Income Taxes
Reconciliation of Segment Adjusted EBITDA to Income/(Loss) Before Income Taxes 15